Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Thumbnail

FDA approves 1st oral treatment for Fabry disease

The FDA has approved migalastat, the first oral medication for the treatment of adults with Fabry disease, the agency announced Aug. 10.

Thumbnail

Man suffers stroke—but gains artistic talents

A 45-year-old man who had a stroke now creates “eye-catching” pictures—a talent he didn’t have before the medical emergency. Wayne Sheppard of the United Kingdom now sells some of his paintings for up to $510 (or £400).

Thumbnail

Dallas hospital uses music therapy to help heal stroke patients

The Music Therapy Program at the Texas Health Presbyterian Hospital in Dallas integrates music into stroke patients’ healing process to help patients relax after stroke. It is also a way to help meet health targets set by patients’ speech therapists.

Red blood cell enzyme may promote endothelial dysfunction in diabetics

Swedish researchers have identified a potential mechanism for the endothelial dysfunction found in patients with type 2 diabetes (T2D): increased expression of the arginase I protein in red blood cells.

Statins underused for the ‘other’ CAD: carotid artery disease

Continued use of statins was associated with a 25 percent reduced risk of major adverse cardiovascular events in patients after carotid revascularization, according to a Canadian study with five years of follow-up. But only about two-thirds of patients were taking moderate to high doses of the drugs prior to their procedures.

Thumbnail

8-plus hours of sleep may increase CVD risk

Research in the Journal of the Journal of the American Heart Association suggests sleeping beyond the recommended seven to eight hours a night can increase the risk of cardiovascular disease (CVD) and death. 

Thumbnail

Novel drug reduces gut byproduct linked to heart attack, stroke

Researchers from the Cleveland Clinic have developed what could become a new class of cardiovascular drugs—one that lowers platelet responsiveness and excessive clot formation by targeting a specific bacteria byproduct in the gut.

Thumbnail

Genetic test could quickly identify Kawasaki disease

A 13-gene signature can separate Kawasaki disease from other febrile and inflammatory conditions, potentially opening the door to blood tests that allow quicker treatment and the prevention of coronary artery aneurysms.